Experiences with a centralised national service for autologous serum eyedrops in England;Erfahrungen mit einem national zentralisierten herstellungsverfahren für eigenserum-augentropfen in England

Ophthalmologe

Volumn 105, Issue 7, 2008, Pages 639-643

  MacLennan, S ^a   Hartwig, D ^b   Geerling, G ^c  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Autologous serum; Drye eyes; Eyedrops; GMP Guidelines; Tears substitute

Indexed keywords

BIOLOGICAL PRODUCT; EYE DROPS;

BLOOD BANK; CORNEA DISEASE; HUMAN; METHODOLOGY; ORGANIZATION AND MANAGEMENT; SERUM; SHORT SURVEY; STANDARD; UNITED KINGDOM;

BIOLOGICAL PRODUCTS; BLOOD BANKS; CORNEAL DISEASES; ENGLAND; HUMANS; OPHTHALMIC SOLUTIONS; SERUM;

EID: 47849089237     PISSN: 0941293X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00347-008-1753-8     Document Type: Short Survey

References (7)

1. Whitcher 2004 Br J Ophthalmol 88 603
2. Fox 1984 Arthritis Rheum 27 459
3. Fujikawa 1981 Lab Invest 45 120
4. Geerling 2004 Br J Ophthalmol 88 1467
5. MHRA (2007) Rules and guidance for pharmaceutical manufacturers and distributors. Pharmaceutical Press, Biggleswade
6. Noble 2004 Br J Ophthalmol 88 647
7. The Blood Safety and Quality Regulations (2005) No 50, 2005